Rethinking Infection Diagnostics in Cystic Fibrosis

• by Mollie Spindler

• September 17, 2026

Photodynamic therapy gains FDA approval for superficial BCC

Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.

• by Kathryn Wighton

• September 15, 2026

• 2 min

ECP 2026: Combined Approach Predicts Metastasis in Prostate Cancer

Integrating spatial transcriptomics and machine learning may predict lymph node metastasis in treatment-naive prostate cancer

• September 17, 2026

• 3 min

Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation

• by Julia Konings, Fleur Mingneau, Serhii Chornyi, Cathrin E. Hansen, Rianne T. M. van der Burgt, Tessa G. van Elk, Laura Bolkaerts, Bo Batens, Gábor Tóth, Ingela Lanekoff, Frédéric M. Vaz, Alessio Cardilli, Marie Sels, Susanne M. A. van der Pol, Helga E. de Vries, Martin Giera, Oliver Werz, Sofie Kessels, Sanne G. S. Verberk, Jeroen F. J. Bogie, Merel Rijnsburger, Jerome J. A. Hendriks, Gijs Kooij

• September 4, 2026